Role of the cancer-associated extracellular matrix in treatment response of patients with clear cell renal cell carcinoma and identification of a novel predictive biomarker for this response
Role of the cancer-associated extracellular matrix in treatment response of patients with clear cell renal cell carcinoma and identification of a novel predictive biomarker for this response
癌症相关细胞外基质在透明细胞肾细胞癌患者治疗反应中的作用以及该反应的新型预测生物标志物的鉴定
批准号：
475986
负责人：
Perreault Alexis
金额：
$7.65万
依托单位：
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-11-01 至 2025-11-01
中文摘要
翻译
在各种类型的肾癌中，肾透明细胞癌(CcRCC)是最常见和最具侵袭性的。批准的治疗大多是针对过度血管形成的药物(抗血管生成药物)和tre。
英文摘要
Among the various types of kidney cancer, clear cell renal cell carcinoma (ccRCC) is the most frequently diagnosed and the most aggressive. Approved treatments are mostly agents that target excessive blood vessel formation (anti-angiogenic agents) and tre
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
